NCT02425592View on ClinicalTrials.gov

Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE)

CompletedOBSERVATIONAL

Enrollment

223

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

May 30, 2022

Study Completion Date

May 31, 2025

Conditions

Prostate Cancer

Trial Locations (2)

06520

Yale University, New Haven

06516

VA Connecticut Healthcare System (VACT), West Haven

All Listed Sponsors

lead

Yale University

OTHER

NCT02425592 - Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE) | Biotech Hunter | Biotech Hunter